New Product Podcast: ZYCORTAL® Suspension
Feb 16, 2017•13 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
The latest installment of VetFolio’s New Product Podcast series features ZYCORTAL® Suspension, from Dechra, a world leader in veterinary endocrinology. ZYCORTAL Suspension contains desoxycorticosterone pivalate (DOCP) which is a mineralocorticoid hormone indicated for use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (Addison’s disease). ZYCORTAL Suspension was formulated and approved specifically for subcutaneous use. For a great refresher on how to diagnoses and manage Addison’s cases presented by Dr. Audrey Cook, please visit www.Dechra-us.com/CE.
For the best experience, listen in Metacast app for iOS or Android